Skip to main content
Log in

Correlation of Immune-Inflammatory Response System (IRS)/Compensatory Immune-Regulatory Reflex System (CIRS) with White Matter Integrity in First-Episode Patients with Schizophrenia

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Several studies have reported compromised white matter integrity, and that some inflammatory mediators may underlie this functional dysconnectivity in the brain of patients with schizophrenia. The immune-inflammatory response system and compensatory immune-regulatory reflex system (IRS/CIRS) are novel biomarkers for exploring the role of immune imbalance in the pathophysiological mechanism of schizophrenia. This study aimed to explore the little-known area regarding the composite score of peripheral cytokines, the IRS/CIRS, and its correlation with white matter integrity and the specific microstructures most affected in schizophrenia. First-episode patients with schizophrenia (FEPS, n = 94) and age- and sex-matched healthy controls (HCs, n = 50) were enrolled in this study. Plasma cytokine levels were measured using enzyme-linked immunosorbent assay (ELISA), and psychopathology was assessed using the Positive and Negative Syndrome Scale (PANSS). The whole brain white matter integrity was measured by fractional anisotropy (FA) from diffusion tensor imaging (DTI) using a 3-T Prisma MRI scanner. The IRS/CIRS in FEPS was significantly higher than that in HCs (p = 1.5 × 10−5) and Cohen’s d effect size was d = 0.74. FEPS had a significantly lower whole-brain white matter average FA (p = 0.032), which was negatively associated with IRS/CIRS (p = 0.029, adjusting for age, sex, years of education, BMI, and total intracranial volume), but not in the HCs (p > 0.05). Among the white matter microstructures, only the cortico-spinal tract was significantly correlated with IRS/CIRS in FEPS (r =  − 0.543, p = 0.0009). Therefore, elevated IRS/CIRS may affect the white matter in FEPS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data Availability

The datasets generated during the current study will be made available from the corresponding author on reasonable request once the dataset has been fully exploited by the authors.

References

  1. Marder SR, Cannon TD (2019) Schizophrenia. N Engl J Med 381(18):1753–1761

    Article  CAS  PubMed  Google Scholar 

  2. Adamczyk P, Plonka O, Kruk D, Jani M, Bladzinski P, Kalisz A et al (2021) On the relation of white matter brain abnormalities and the asociality symptoms in schizophrenia outpatients - a DTI study. Acta Neurobiol Exp (Wars) 81(1):80–95

    Article  PubMed  Google Scholar 

  3. Stahl SM (2018) Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate. CNS Spectr 23(3):187–191

    Article  PubMed  Google Scholar 

  4. Watkins CC, Andrews SR (2016) Clinical studies of neuroinflammatory mechanisms in schizophrenia. Schizophr Res 176(1):14–22

    Article  PubMed  Google Scholar 

  5. Lizano P, Lutz O, Xu Y, Rubin LH, Paskowitz L, Lee AM et al (2021) Multivariate relationships between peripheral inflammatory marker subtypes and cognitive and brain structural measures in psychosis. Mol Psychiatry 26(7):3430–3443

    Article  CAS  PubMed  Google Scholar 

  6. Michalczyk A, Tyburski E, Podwalski P, Waszczuk K, Rudkowski K, Kucharska-Mazur J et al (2022) Serum inflammatory markers and their associations with white matter integrity of the corpus callosum in schizophrenia patients and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 116:110510

    Article  CAS  PubMed  Google Scholar 

  7. Malashenkova IK, Krynskiy SA, Ogurtsov DP, Mamoshina MV, Zakharova NV, Ushakov VL et al (2018) A role of the immune system in the pathogenesis of schizophrenia. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova 118(12)

  8. Najjar S, Pearlman DM (2015) Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res 161(1):102–112

    Article  PubMed  Google Scholar 

  9. Lee EE, Hong S, Martin AS, Eyler LT, Jeste DV (2017) Inflammation in schizophrenia: cytokine levels and their relationships to demographic and clinical variables. Am J Geriatr Psychiatry 25(1):50–61

    Article  PubMed  Google Scholar 

  10. Lesh TA, Careaga M, Rose DR, McAllister AK, Van de Water J, Carter CS et al (2018) Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms. J Neuroinflammation 15(1):165

  11. Wu ZW, Yu HH, Wang X, Guan HY, Xiu MH, Zhang XY (2021) Interrelationships between oxidative stress, cytokines, and psychotic symptoms and executive functions in patients with chronic schizophrenia. Psychosom Med 83(5):485–491

    Article  CAS  PubMed  Google Scholar 

  12. Dahan S, Bragazzi NL, Yogev A, Bar-Gad M, Barak V, Amital H et al (2018) The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia. Psychiatry Res 268:467–472

    Article  CAS  PubMed  Google Scholar 

  13. Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21(12):1696–1709

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Maes M, Carvalho AF (2018) The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder. Mol Neurobiol 55(12):8885–8903

    Article  CAS  PubMed  Google Scholar 

  15. Noto MN, Maes M, Vargas Nunes SO, Ota VK, Rossaneis AC, Verri WA Jr et al (2019) Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis. Eur Neuropsychopharmacol 29(3):416–431

    Article  CAS  PubMed  Google Scholar 

  16. Maes M, Berk M, Goehler L, Song C, Anderson G, Gałecki P et al (2012) Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med 10:66

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Maes M, Plaimas K, Suratanee A, Noto C, Kanchanatawan B (2021) First episode psychosis and schizophrenia are systemic neuro-immune disorders triggered by a biotic stimulus in individuals with reduced immune regulation and neuroprotection. Cells 10(11)

  18. Moustafa SR, Al-Rawi KF, Stoyanov D, Al-Dujaili AH, Supasitthumrong T, Al-Hakeim HK et al (2020) The endogenous opioid system in schizophrenia and treatment resistant schizophrenia: increased plasma endomorphin 2, and kappa and mu opioid receptors are associated with interleukin-6. Diagnostics (Basel) 10(9)

  19. Roomruangwong C, Noto C, Kanchanatawan B, Anderson G, Kubera M, Carvalho AF et al (2020) The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia. Mol Neurobiol 57(2):778–797

    Article  CAS  PubMed  Google Scholar 

  20. Noto MN, Maes M, Vargas Nunes SO, Ota VK, Cavalcante D, Oliveira G et al (2021) BDNF in antipsychotic naive first episode psychosis: effects of risperidone and the immune-inflammatory response system. J Psychiatr Res 141:206–213

    Article  PubMed  Google Scholar 

  21. Chen W, Gou M, Wang L, Li N, Li W, Tong J et al (2023) Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia. Eur Neuropsychopharmacol 72:18–29

    Article  CAS  PubMed  Google Scholar 

  22. Martins PLB, Moura IA, Mendes G, Ribeiro V, Arnaud A, Gama CS et al (2023) Immunoinflammatory and oxidative alterations in subjects with schizophrenia under clozapine: a meta-analysis. Eur Neuropsychopharmacol 73:82–95

    Article  CAS  PubMed  Google Scholar 

  23. Wang Y, Wei Y, Edmiston EK, Womer FY, Zhang X, Duan J et al (2020) Altered structural connectivity and cytokine levels in schizophrenia and genetic high-risk individuals: associations with disease states and vulnerability. Schizophr Res

  24. Prasad KM, Upton CH, Nimgaonkar VL, Keshavan MS (2015) Differential susceptibility of white matter tracts to inflammatory mediators in schizophrenia: an integrated DTI study. Schizophr Res 161(1):119–125

    Article  PubMed  Google Scholar 

  25. Tong J, Zhou Y, Huang J, Zhang P, Fan F, Chen S et al (2021) N-methyl-D-aspartate receptor antibody and white matter deficits in schizophrenia treatment-resistance. Schizophr Bull 47(5):1463–1472

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kraguljac NV, Anthony T, Morgan CJ, Jindal RD, Burger MS, Lahti AC (2021) White matter integrity, duration of untreated psychosis, and antipsychotic treatment response in medication-naïve first-episode psychosis patients. Mol Psychiatry 26(9):5347–5356

    Article  CAS  PubMed  Google Scholar 

  27. Stapel B, Sieve I, Falk CS, Bleich S, Hilfiker-Kleiner D, Kahl KG (2018) Second generation atypical antipsychotics olanzapine and aripiprazole reduce expression and secretion of inflammatory cytokines in human immune cells. J Psychiatr Res 105:95–102

    Article  PubMed  Google Scholar 

  28. Li F, Lui S, Yao L, Ji GJ, Liao W, Sweeney JA et al (2018) Altered white matter connectivity within and between networks in antipsychotic-naive first-episode schizophrenia. Schizophr Bull 44(2):409–418

    Article  PubMed  Google Scholar 

  29. Chwa WJ, Tishler TA, Raymond C, Tran C, Anwar F, Villablanca JP et al (2020) Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients. Schizophr Res 222:397–410

    Article  PubMed  PubMed Central  Google Scholar 

  30. Kahn RS, Sommer IE (2015) The neurobiology and treatment of first-episode schizophrenia. Mol Psychiatry 20(1):84–97

    Article  CAS  PubMed  Google Scholar 

  31. Gou M, Pan S, Tong J, Zhou Y, Han J, Xie T et al (2021) Effects of microRNA-181b-5p on cognitive deficits in first-episode patients with schizophrenia: Mediated by BCL-2. J Psychiatr Res 136:358–365

    Article  PubMed  Google Scholar 

  32. Kochunov P, Huang J, Chen S, Li Y, Tan S, Fan F et al (2019) White matter in schizophrenia treatment resistance. Am J Psychiatry 176(10):829–838

    Article  PubMed  PubMed Central  Google Scholar 

  33. Jahanshad N, Kochunov PV, Sprooten E, Mandl RC, Nichols TE, Almasy L et al (2013) Multi-site genetic analysis of diffusion images and voxelwise heritability analysis: a pilot project of the ENIGMA-DTI working group. Neuroimage 81:455–469

    Article  PubMed  Google Scholar 

  34. Cohen J (1992) A power primer. Psychol Bull 112(1):155–159

    Article  CAS  PubMed  Google Scholar 

  35. Eleni P, Georgia P, Constantine P, Efstratios K, Georgios V, Nikolaos K et al (2021) Functional brain imaging of speeded decision processing in Parkinson’s disease and comparison with schizophrenia. Psychiatry Res Neuroimaging 314:111312

    Article  PubMed  Google Scholar 

  36. Erhardt S, Schwieler L, Imbeault S, Engberg G (2017) The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology 112(Pt B):297–306

    Article  CAS  PubMed  Google Scholar 

  37. Noyan H, Erdağ E, Tüzün E, Yaylım İ, Küçükhüseyin Ö, Hakan MT et al (2021) Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings. Schizophr Res 229:27–37

    Article  CAS  PubMed  Google Scholar 

  38. Mendiola AS, Cardona AE (2018) The IL-1beta phenomena in neuroinflammatory diseases. J Neural Transm (Vienna) 125(5):781–795

    Article  CAS  PubMed  Google Scholar 

  39. Noto MN, Maes M, Nunes SOV, Ota VK, Rossaneis AC, Verri WA Jr et al (2019) Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis. Eur Neuropsychopharmacol 29(3):416–431

    Article  CAS  PubMed  Google Scholar 

  40. Derecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A, Lynch KR et al (2010) Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med 207(5):1067–1080

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Walker KA (2018) Inflammation and neurodegeneration: chronicity matters. Aging (Albany NY) 11(1):3–4

    Article  PubMed  Google Scholar 

  42. Benedetti F, Poletti S, Hoogenboezem TA, Mazza E, Ambree O, de Wit H et al (2016) Inflammatory cytokines influence measures of white matter integrity in bipolar disorder. J Affect Disord 202:1–9

    Article  CAS  PubMed  Google Scholar 

  43. Dietz AG, Goldman SA, Nedergaard M (2020) Glial cells in schizophrenia: a unified hypothesis. Lancet Psychiatry 7(3):272–281

    Article  PubMed  Google Scholar 

  44. Favrais G, van de Looij Y, Fleiss B, Ramanantsoa N, Bonnin P, Stoltenburg-Didinger G et al (2011) Systemic inflammation disrupts the developmental program of white matter. Ann Neurol 70(4):550–565

    Article  CAS  PubMed  Google Scholar 

  45. Seki Y, Kato TA, Monji A, Mizoguchi Y, Horikawa H, Sato-Kasai M et al (2013) Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-γ-stimulated microglia in co-culture model. Schizophr Res 151(1–3):20–28

    Article  PubMed  Google Scholar 

  46. Zhou Y, Zhang J, Wang L, Chen Y, Wan Y, He Y et al (2017) Interleukin-1beta impedes oligodendrocyte progenitor cell recruitment and white matter repair following chronic cerebral hypoperfusion. Brain Behav Immun 60:93–105

    Article  CAS  PubMed  Google Scholar 

  47. Pu H, Zheng X, Jiang X, Mu H, Xu F, Zhu W et al (2021) Interleukin-4 improves white matter integrity and functional recovery after murine traumatic brain injury via oligodendroglial PPARgamma. J Cereb Blood Flow Metab 41(3):511–529

    Article  CAS  PubMed  Google Scholar 

  48. Fu G, Zhang W, Dai J, Liu J, Li F, Wu D et al (2019) Increased peripheral interleukin 10 relate to white matter integrity in schizophrenia. Front Neurosci 13(FEB)

  49. Goudarzi S, Gilchrist SE, Hafizi S (2020) Gas6 induces myelination through anti-inflammatory IL-10 and TGF-beta upregulation in white matter and glia. Cells 9(8)

  50. Zhang J, Yang L, Fang Z, Kong J, Huang Q, Xu H (2018) Adenosine promotes the recovery of mice from the cuprizone-induced behavioral and morphological changes while effecting on microglia and inflammatory cytokines in the brain. J Neuroimmune Pharmacol 13(3):412–425

    Article  PubMed  Google Scholar 

  51. Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA (2013) Glia and epilepsy: excitability and inflammation. Trends Neurosci 36(3):174–184

    Article  CAS  PubMed  Google Scholar 

  52. Zhang C, Xue H, Lei Y, Xu W, K. CRC, Xin Y et al (2012) Motor coordination and white matter integrity in prefrontal lobe and corticospinal tract in first-episode schizophrenia. Chin Ment Health J 26(8):561-5

  53. Matrone M, Kotzalidis GD, Romano A, Bozzao A, Cuomo I, Valente F et al (2022) Treatment-resistant schizophrenia: addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients. Prog Neuropsychopharmacol Biol Psychiatry 114:110493

    Article  CAS  PubMed  Google Scholar 

  54. Sui J, He H, Pearlson GD, Adali T, Kiehl KA, Yu Q et al (2013) Three-way (N-way) fusion of brain imaging data based on mCCA+jICA and its application to discriminating schizophrenia. Neuroimage 66:119–132

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank all of the study participants and staff.

Funding

This work was supported by the capital health research and development of special (2022–1-2131); the National Natural Science Foundation of China grants 82171507, 81761128021, and 81771452; the National Institute of Health grant R01MH112180; the Estonian Research Council-European Union Regional Developmental Fund Mobilitas Plus Program No. MOBTT77 and the Estonian Research Council personal research funding team grant project No. PRG878; the National Natural Science Foundation of China (82001415); and the Capital’s Funds for Health Improvement and Research (CFH2020-2–2134).

Author information

Authors and Affiliations

Authors

Contributions

Li Tian, Yunlong Tan, and L. Elliot Hong designed the project and obtained the funding for this study. Mengzhuang Gou, Wei Li, Jinghui Tong, Yanfang Zhou, Ting Xie, Ting Yu, Wei Feng, Yanli Li, Song Chen, Shujuan Pan, Ping Zhang, and Junchao Huang were responsible for recruiting patients, performing clinical ratings, neuroimaging, and collecting samples. Mengzhuang Gou analyzed all the data and wrote the paper. Yunlong Tan and Li Tian are responsible for the integrity of data and the accuracy of data analysis. Baopeng Tian, Zhiren Wang, Shuping Tan, Xingguang Luo, Chiang-Shan R. Li, and L. Elliot Hong were invited in evolving the ideas and editing the manuscript. All authors have contributed to and have approved the final manuscript.

Corresponding authors

Correspondence to Li Tian or Yunlong Tan.

Ethics declarations

Ethics Approval and Consent to Participate

All study-related procedures were performed only after the participants enrolled in this study provided written informed consent. The study protocol was approved by the Ethics Committee of Beijing Huilongguan Hospital.

Consent for Publication

Not applicable.

Conflict of Interest

LEH has received or plans to receive research funding or consulting fees on research projects from Mitsubishi, Your Energy Systems LLC, Neuralstem, Taisho, Heptares, Pfizer, Luye Pharma, Sound Pharma, IGC Pharma, Takeda, and Regeneron. None was involved in the design, analysis, or outcomes of the study. All other authors declare no competing commercial and financial interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 670 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gou, M., Li, W., Tong, J. et al. Correlation of Immune-Inflammatory Response System (IRS)/Compensatory Immune-Regulatory Reflex System (CIRS) with White Matter Integrity in First-Episode Patients with Schizophrenia. Mol Neurobiol 61, 2754–2763 (2024). https://doi.org/10.1007/s12035-023-03694-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-023-03694-0

Keywords

Navigation